Patient-reported symptoms are a more reliable predictor of the societal burden compared to established physician-reported activity indices in inflammatory bowel disease: a cross-sectional study

The LUCID study: living with ulcerative colitis; identifying the socioeconomic burden in Europe

(2021) Leonardo Ruiz-Casas et al.   BMC GASTROENTEROLOGY

Health-related quality of life, work productivity and costs related to patients with inflammatory bowel disease in Austria

(2020) Evelyn Walter et al.   JOURNAL OF MEDICAL ECONOMICS

Indirect costs associated with ulcerative colitis: a systematic literature review of real-world data

(2019) Joelle Constantin et al.   BMC GASTROENTEROLOGY

Short-term response in new users of anti-TNF predicts long-term productivity and non-disability: analysis of Czech ATTRA ankylosing spondylitis biologic registry

(2019) Jan Tužil et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

The Association of Disease Activity, BMI and Phase Angle with Vitamin D Deficiency in Patients with IBD

(2019) Maria Chiara Mentella et al.   Nutrients

Health-Related Quality of Life and Work-Related Outcomes for Patients With Mild-to-Moderate Ulcerative Colitis and Remission Status Following Short-Term and Long-Term Treatment With Multimatrix Mesalamine: A Prospective, Open-Label Study

(2018) Aaron Yarlas et al.   INFLAMMATORY BOWEL DISEASES

ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 2: IBD scores and general principles and technical aspects

(2018) Andreas Sturm et al.   Journal of Crohns & Colitis

Crohn's disease

(2017) Joana Torres et al.   LANCET

Ulcerative colitis

(2017) Ryan Ungaro et al.   LANCET

Indirect costs of inflammatory bowel diseases: Crohn’s disease and ulcerative colitis. A systematic review

(2016) Paweł Kawalec   Archives of Medical Science

Health-Related Quality of Life Impairment and Indirect Cost of Crohn’s Disease: A Self-Report Study in Poland

(2016) Przemysław Holko et al.   PLoS One

How to Estimate Productivity Costs in Economic Evaluations

(2014) Marieke Krol et al.   PHARMACOECONOMICS

Relationship between disease severity and quality of life and assessment of health care utilization and cost for ulcerative colitis in Australia: A cross-sectional, observational study

(2013) Peter R. Gibson et al.   Journal of Crohns & Colitis

Lost Productivity in Four European Countries among Patients with Rheumatic Disorders

(2012) Saskia Knies et al.   PHARMACOECONOMICS

Measuring and valuing productivity loss due to poor health: A critical review

(2010) Wei Zhang et al.   SOCIAL SCIENCE & MEDICINE

The value of productivity: human-capital versus friction-cost method

(2009) W B van den Hout   ANNALS OF THE RHEUMATIC DISEASES

Resource use and societal costs for Crohnʼs disease in Sweden

(2009) Johan Mesterton et al.   INFLAMMATORY BOWEL DISEASES

Good Research Practices for Comparative Effectiveness Research: Approaches to Mitigate Bias and Confounding in the Design of Nonrandomized Studies of Treatment Effects Using Secondary Data Sources: The International Society for Pharmacoeconomics and Outcomes Research Good Research Practices for Retrospective Database Analysis Task Force Report—Part II

(2009) Emily Cox et al.   VALUE IN HEALTH

Good Research Practices for Comparative Effectiveness Research: Analytic Methods to Improve Causal Inference from Nonrandomized Studies of Treatment Effects Using Secondary Data Sources: The ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report—Part III

(2009) Michael L. Johnson et al.   VALUE IN HEALTH

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies

(2008) Erik von Elm et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

The Direct and Indirect Cost Burden of Crohnʼs Disease and Ulcerative Colitis

(2008) Teresa B. Gibson et al.   JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE